Please enable JavaScript.
Coggle requires JavaScript to display documents.
Nanex FY27 - Coggle Diagram
Nanex FY27
Scenario 1:
potential BU case
replace 255 with Nanex,
achieve higher ASP
50k
ASP: JPY 8500
additional revenue & profit: 50kxJPY1,500
JPY75mio
New business
40k @ ASP JPY 8,500
additional revenue: JPY340mio
Scenario 2:
bad case scenario
new Busienss,
but lower than in scenario 1
20k unist x JPY 8,500
JPY 170mio
20k unist x JPY 8,500
JPY 170mio
replace 255 with Nanex
achieve higher ASP
reduce conversion of 255 to Nanex to 20k units
additional revenue & profit = 20k x JPY 1,500 = JPY 30mio
Scenario 3:
worst case scenario
no Nanex in FY27
launch of Nanex
not feasible as AFI discontinuation
starts 2029
opportinity loss No. 1: because no Nanex
JPY 1,000mio at ansd ASP of ~JPY8k
Opportunity loss No. 2: reduction of 255 due to non-competitiveness
loss of 40k units = JPY 300mio
redution of ASP by JPY 500 = JPY180mio (360k x JPY 500)
Reputational damage with Dealers and Customers
In FY26 we conducted already 3 dealer events
with ~ 200 dealers
Nanex is already rolled out to ~20 clinics/hospitals
Motivational drag for Sales Team
Nanex launch was already postponed twice due to internal problems